Transcript
A (0:01)
Welcome to AOFAS Ortho Podcast, where leaders in foot and ankle orthopedic surgery discuss the issues that affect you and your practice. Please note that the views expressed on this podcast do not necessarily represent the views of the AOFAS or its members.
B (0:27)
2025 AOFAS pillar Ron Smith.
C (0:31)
We're just finishing up here. We just finished our AOFAS Pillars Awards and Ron Smith was the awardee for today and Tom Harris was the one who presented to him. And we were just trying to get some feelings of what this society has meant for you. And you know how it has changed over the years, perhaps.
D (0:51)
Well, then it certainly has changed in terms of the AOFAs. And in fact, when I was involved early on, it was AOFs, not AOFAs now. And because in 1983 we incorporated the title of ankle, we didn't want to just be foot because we did a lot of ankle. And so the evolution of the Society really changed dramatically with Pierce Scranton. And you heard some of the things commented about Pierce, but we really were a small shop, relatively, because we didn't have the revenue. And when he started relationships with industry and really introduced foot and ankle to industry and industry to foot and ankle, it just changed things in terms of our advancements in techniques, implants and revenue. And so we have so many more programs than we were able to provide to our membership before that change.
B (1:58)
Where's an area that you think the Society can grow the most based on how you've seen it grow? Where would you like to see it grow in the future?
D (2:07)
Not with major changes, but to me, the two priorities from my standpoint, our recruitment of orthopedists to the field of foot and ankle. We need more, more young people like Tom Harris, who was a fellow years ago. And so I think recruitment and the Foot Society is doing a terrific job with their programs, their resident programs and scholarships. We still need to do more in terms of that recruitment. And the second priority from my standpoint, is clinical research. It's clinical research that really helps us improve our diagnostic accuracy and our treatment outcomes. And unfortunately, clinical research, when you really, you know, I'd like to see the day where we really have more patients coming back for examinations at one year and where appropriate, five years. You know, we have a lot of good research with chart reviews, but we all know you don't think of all the things you want answered one year, two years down the line without really seeing those patients. So that's a time cost, that's a dollar cost to really do clinical research. Where you see patients back, so that's a priority. I think that would be beneficial.
